PMC Articles for MedGen (Select 65916) - PMC

Links from MedGen

Items: 1 to 20 of 158

<< First< Prev

Page of 8

Select item 104397341.

Mesenchymal Hamartoma With Elevated Alpha-Fetoprotein: A Diagnostic Pitfall

Amine Naggar, Hajar Andour, Hamza Bensaghir, Badr Kabila, Chaimae Ben Driss, Soukaina El Aouni, Monim Ochan, Mounir Kisra, Najat Lamalmi, Siham El Haddad, Nazik Allali, Latifa Chat

Glob Pediatr Health. 2023; 10: 2333794X231193560. Published online 2023 Aug 18. doi: 10.1177/2333794X231193560

PMCID:: PMC10439734

Article PubReader PDF–1005K Cite

Select item 102494252.

Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non–Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2

Richard S Finn, Thomas Yau, Chih-Hung Hsu, Enrico N De Toni, Lipika Goyal, Peter R Galle, ShuKui Qin, Sujata Rao, Fangfang Sun, Chunxiao Wang, Ryan C Widau, Andrew X Zhu

Oncologist. 2022 Dec; 27(12): e938–e948. Published online 2022 Oct 3. doi: 10.1093/oncolo/oyac183

PMCID:: PMC10249425

Article PubReader PDF–1.3M Cite

Select item 96629303.

Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials

Josep M. Llovet, Amit G. Singal, Augusto Villanueva, Richard S. Finn, Masatoshi Kudo, Peter R. Galle, Masafumi Ikeda, Sophie Callies, Louise M. McGrath, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Elena Gonzalez-Gugel, Andrew X. Zhu

Clin Cancer Res. 2022 Jun 1; 28(11): 2297–2305. Published online 2022 Mar 1. doi: 10.1158/1078-0432.CCR-21-4000

PMCID:: PMC9662930

Article PubReader PDF–857K Cite

Select item 95629264.

Ramucirumab as second-line treatment in Chinese patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib (REACH-2 China): A randomised, multicentre, double-blind study

Guoliang Shao, Yuxian Bai, Xianglin Yuan, Xiaomin Chen, Shanzhi Gu, Kangsheng Gu, Chunhong Hu, Houjie Liang, Yabing Guo, Jufeng Wang, Chia-Jui Yen, Victor Ho-Fun Lee, Chunxiao Wang, Ryan C. Widau, Wanli Zhang, Junjun Liu, Qiang Zhang, Shukui Qin

eClinicalMedicine. 2022 Dec; 54: 101679. Published online 2022 Oct 6. doi: 10.1016/j.eclinm.2022.101679

PMCID:: PMC9562926

Article PubReader PDF–1002K Cite

Select item 95003495.

Case report: Hepatic epithelioid angiomyolipoma with elevated alpha-fetoprotein and a history of breast cancer

Xiaowei Zhang, Jun Chen, Bifei Huang, Lihong Wang

Front Surg. 2022; 9: 991228. Published online 2022 Sep 9. doi: 10.3389/fsurg.2022.991228

PMCID:: PMC9500349

Article PubReader PDF–1.2M Cite

Select item 93027316.

Elevated alpha-fetoprotein in asymptomatic adults: Clinical features, outcome, and association with body composition

Sangmi Jang, Gwang Hyeon Choi, Won Chang, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong

PLoS One. 2022; 17(7): e0271407. Published online 2022 Jul 21. doi: 10.1371/journal.pone.0271407

PMCID:: PMC9302731

Article PubReader PDF–923K Cite

Select item 90321577.

Elevated Alpha-Fetoprotein in Infantile-Onset Niemann-Pick Type C Disease with Liver Involvement

Dror Kraus, Huda Abdelrahim, Orith Waisbourd-Zinman, Elena Domin, Avraham Zeharia, Orna Staretz-Chacham

Children (Basel) 2022 Apr; 9(4): 545. Published online 2022 Apr 12. doi: 10.3390/children9040545

PMCID:: PMC9032157

Article PubReader PDF–507K Cite

Select item 87980338.

Primary neuroendocrine carcinoma of the breast with markedly elevated alpha-fetoprotein: a case report

Jia Wang, Xichen Wang, Wenlong Du, Yuanxian Guo, Xiaoping Yang, Jiebin Pan, Lanning Yin

Transl Cancer Res. 2021 May; 10(5): 2503–2508. doi: 10.21037/tcr-20-3391

PMCID:: PMC8798033

Article PubReader PDF–2.2M Cite

Select item 85641419.

Rapid Response to the Combination of Lenvatinib and Sintilimab in a Pancreatic Acinar Cell Carcinoma Patient With Elevated Alpha-Fetoprotein: A Case Report

Lanqun Qin, Jie Shen, Yueling Yang, Zhengyun Zou

Front Oncol. 2021; 11: 692480. Published online 2021 Oct 20. doi: 10.3389/fonc.2021.692480

PMCID:: PMC8564141

Article PubReader PDF–2.1M Cite

Select item 852792210.

Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)

Masatoshi Kudo, Richard S. Finn, Manabu Morimoto, Kun-Ming Rau, Masafumi Ikeda, Chia-Jui Yen, Peter R. Galle, Josep M. Llovet, Bruno Daniele, Ho Yeong Lim, David W. McIlwain, Reigetsu Yoshikawa, Kenichi Nakamura, Kun Liang, Chunxiao Wang, Paolo Abada, Ryan C. Widau, Andrew X. Zhu

Liver Cancer. 2021 Sep; 10(5): 451–460. Published online 2021 Jul 12. doi: 10.1159/000516605

PMCID:: PMC8527922

Article PubReader PDF–415K Cite

Select item 817114011.

Infantile mesenchymal hamartoma of the liver with elevated alpha fetoprotein

Liem Thanh Le, Hai Thanh Phan, Trung Sao Nguyen, Khai Dinh Truong, Dang Thanh Nguyen, Toan Bao Nguyen, Thuy Thi Thu Pham

BJR Case Rep. 2021 May 1; 7(3): 20200196. Published online 2021 Jan 28. doi: 10.1259/bjrcr.20200196

PMCID:: PMC8171140

Article PubReader PDF–854K Cite

Select item 808181412.

Multiple hepatic inflammatory pseudotumors with elevated alpha-fetoprotein and alpha-fetoprotein lectin 3 fraction with various PET accumulations: a case report

Masataka Maruno, Katsunori Imai, Yosuke Nakao, Yuki Kitano, Takayoshi Kaida, Kosuke Mima, Hiromitsu Hayashi, Yo-Ichi Yamashita, Yoshiki Mikami, Hideo Baba

Surg Case Rep. 2021 Dec; 7: 107. Published online 2021 Apr 28. doi: 10.1186/s40792-021-01188-6

PMCID:: PMC8081814

Article PubReader PDF–2.7M Cite

Select item 761114513.

Serum Levels of Alpha Fetoprotein Increased More Than 10 Years Before Detection of Hepatocellular Carcinoma

David M Hughes, Sarah Berhane, CA Emily de Groot, Hidenori Toyoda, Toshifumi Tada, Takashi Kumada, Shinji Satomura, Naoshi Nishida, Masatoshi Kudo, Toru Kimura, Yukio Osaki, Ruwanthi Kolamunage-Dona, Ruben Amoros Salvador, Tom Bird, Marta Garcĺa-Fiñana, Philip Johnson

Clin Gastroenterol Hepatol. Author manuscript; available in PMC 2021 Jul 8.

Published in final edited form as: Clin Gastroenterol Hepatol. 2021 Jan 1; 19(1): 162–170.e4. Published online 2020 May 8. doi: 10.1016/j.cgh.2020.04.084

PMCID:: PMC7611145

Article PubReader PDF–1.4M Cite

Select item 750622814.

Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies

Chia-Jui Yen, Masatoshi Kudo, Ho-Yeong Lim, Chih-Hung Hsu, Arndt Vogel, Giovanni Brandi, Rebecca Cheng, Ioana Simona Nitu, Paolo Abada, Yanzhi Hsu, Andrew X. Zhu, Yoon-Koo Kang

Liver Cancer. 2020 Aug; 9(4): 440–454. Published online 2020 May 5. doi: 10.1159/000506946

PMCID:: PMC7506228

Article PubReader PDF–662K Cite

Select item 743787315.

Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials

Andrew X Zhu, Ryan D Nipp, Richard S Finn, Peter R Galle, Josep M Llovet, Jean-Frederic Blanc, Takuji Okusaka, Ian Chau, David Cella, Allicia Girvan, Jonathon Gable, Lee Bowman, Chunxiao Wang, Yanzhi Hsu, Paolo B Abada, Masatoshi Kudo

ESMO Open. 2020; 5(4): e000797. Published online 2020 Aug 18. doi: 10.1136/esmoopen-2020-000797

PMCID:: PMC7437873

Article PubReader PDF–1.8M Cite

Select item 724223516.

Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial

Masatoshi Kudo, Takuji Okusaka, Kenta Motomura, Izumi Ohno, Manabu Morimoto, Satoru Seo, Yoshiyuki Wada, Shinpei Sato, Tatsuya Yamashita, Masayuki Furukawa, Takeshi Aramaki, Seijin Nadano, Kazuyoshi Ohkawa, Hirofumi Fujii, Toshihiro Kudo, Junji Furuse, Hiroki Takai, Gosuke Homma, Reigetsu Yoshikawa, Andrew X. Zhu

J Gastroenterol. 2020; 55(6): 627–639. Published online 2020 Feb 27. doi: 10.1007/s00535-020-01668-w